Natco Pharma has launched two Chlorantraniliprole (CTPR) pesticide formulated combination products under the brand names: a. NATVOL: Chlorantraniliprole 8.8% + Thiamethoxam 17.5% SC; and ...

Natco Pharma shares were flat at Rs 912.2 at 10.10 am after the company made an investment of $2 million in Delaware-based ISCA Inc on August 30. ISCA Inc had a turnover of $9,338,426 for the year ...

Natco Pharma's move to invest in ISCA Inc. mirrors its dedication to innovation and environmentally conscious practices. ... The company's expertise lies in producing pesticides that disrupt the ...

Some stocks in the Nifty 500 have shown early signs of momentum, but they are still flying under the radar with weekly ...

Stock Market Today: Natco Pharma share price gained more than 7% to scale 52 week highs on Thursday during the intraday trades. The robust US sales growth led by Revlimid generics is driving earnings.

HC restrains Natco Pharma from manufacturing, using ... While the US company submitted it has been supplying insect killing pesticides to Indian farmers for decades Natco questioned the patent ...

At 09:45 hrs Natco Pharma was quoting at Rs 653, up Rs 15.60 or 2.45 percent on the BSE. The share touched a 52-week high of Rs 942.15 and a 52-week low of Rs 600.10 on 17 January and 12 September ...

PARSIPPANY, N.J.--(BUSINESS WIRE)--Natco Pharma Limited, a research and development (R&D)-focused pharmaceutical company based in India, today announced that DASH Pharmaceuticals, a company that ...

Natco Pharma Ltd isn’t your run-of-the-mill pharmaceutical company. It’s a story of calculated risks, high-stakes bets, and a fair bit of drama. At the heart of this journey is Rajeev ...

Natco Pharma is mulling acquisitions in the Rest of the World (RoW) markets to strengthen its base business. “The acquisition space is to strengthen our base business. We have the money to do it ...

Natco Pharma Limited shared that DASH Pharmaceuticals, a company that markets, sells and distributes generic pharmaceutical products, has officially transitioned to Natco Pharma USA, the U.S ...